Bupropion attenuates morphine tolerance and dependence: Possible role of glutamate, norepinephrine, inflammation, and oxidative stress.

@article{Hamdy2018BupropionAM,
  title={Bupropion attenuates morphine tolerance and dependence: Possible role of glutamate, norepinephrine, inflammation, and oxidative stress.},
  author={M. M. Hamdy and M. Elbadr and A. Barakat},
  journal={Pharmacological reports : PR},
  year={2018},
  volume={70 5},
  pages={
          955-962
        }
}
BACKGROUND Morphine - the main pillar of nociceptive pain management - systemic use is associated with development of tolerance and dependence. Tolerance and dependence lay a heavy burden in clinical pain management settings. An added weight to this dilemma is that effective, safe, and tolerable solution to this problem is still beyond reach. Antidepressants were reported as possible alleviators of opioid tolerance and dependence. One of the increasingly used antidepressant in clinical practice… Expand
Evaluating the Effects of Chronic Administration of Natural Honey on the Development of Morphine Dependence in Rats
Background According to the previous studies, the exact mechanism of dependence on opioids and withdrawal syndrome has not been fully understood. Aim This study was aimed to evaluate the effects ofExpand
Erratum to "Evaluating the Effects of Chronic Administration of Natural Honey on the Development of Dependence on Morphine in the Male Rats"
TLDR
The results indicated that chronic administration of NHO had beneficial effects in reducing symptoms of morphine withdrawal syndrome, and this effect is probably due to the anti-inflammatory effect caused by the polyphenolic compounds in honey. Expand
Endogenous Opiates and Behavior: 2018
This paper is the forty-first consecutive installment of the annual anthological review of research concerning the endogenous opioid system, summarizing articles published during 2018 that studiedExpand
N-acetylcysteine mitigates acute opioid withdrawal behaviors and CNS oxidative stress in neonatal rats
TLDR
This is the first study to demonstrate acute opioid withdrawal neurochemical changes in vivo in neonatal OD and suggest N-acetylcysteine is a potential novel treatment for NAS. Expand
Effects of Royal Jelly on the Prefrontal Cortex in a Rat - Morphine Toxicity Model
Introduction: Royal jelly (RJ) is a honey bee secretion with numerous medicinal properties and antioxidant activities. Morphine is a major risk factor in the development of functional disorders inExpand
m-Trifluoromethyl-diphenyl diselenide (m-CF3-PhSe)2 modulates the hippocampal neurotoxic adaptations and abolishes a depressive-like phenotype in a short-term morphine withdrawal in mice
TLDR
Investigation of whether (m-CF3-PhSe)2 attenuates the physical signs and the depressive-like phenotype during morphine withdrawal through its neuroprotective effects on oxidative stress, the NMDA receptor and the proBDNF/mBDNF signaling in the hippocampus of mice shows that treatment modulated the hippocampal neurotoxic adaptations and abolished the depressive like phenotype following morphine withdrawal in mice. Expand
Falcaria vulgaris attenuates morphine toxicity in prefrontal cortex in rats
TLDR
It seems that F. vulgaris administration improves brain’s prefrontal region injury in rats due to morphine as well as increasing significantly nitrite oxide level and total antioxidant capacity and decreased the number of neuronal dendritic spines and neurons. Expand
Improvement of Petroselinum crispum on Morphine Toxicity in Prefrontal Cortex in Rats
TLDR
It seems that the administration of P. Crispum extract protects the animals against oxidative stress and nitrite oxide, also improves some PC parameters including the number of neurons, and dendritic spines because of the morphine application. Expand
Drug repurposing for opioid use disorders: integration of computational prediction, clinical corroboration, and mechanism of action analyses
TLDR
An integrated drug repurposing strategy is presented that combines computational prediction, clinical corroboration using electronic health records (EHRs) of over 72.9 million patients and mechanisms of action analysis and identified five repurposed candidate drugs that might be of value for treating OUD patients, including those suffering from comorbid conditions. Expand
Predictors of serious adverse drug events from opioids: Results from the Food and Drug Administration Adverse Events Reporting System.
TLDR
Results provide risk data helpful to share with people who use prescribed opioids for self-management of pain and encourage practitioners to continue to avoid prescribing benzodiazepines and other sedatives when opioids are used. Expand

References

SHOWING 1-10 OF 58 REFERENCES
Protective effect of bupropion on morphine tolerance and dependence in mice.
TLDR
The results of the present study suggest the potential use of bupropion in tolerance and dependence. Expand
Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor.
TLDR
It is demonstrated for the first time that venlafaxine strongly attenuates morphine withdrawal and morphine-induced reaquisition of morphine CPP. Expand
Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats
TLDR
The effectiveness of morphine and bupropion to reverse formalin effects agrees with other evidence that these drugs block pain-depressed behavior in rats and relieve neuropathic pain in humans and does not support the use of THC to treat neuropathy pain. Expand
A dose-response study on the efficacy of tricyclic antidepressants on reducing morphine-withdrawal symptoms.
TLDR
Amoxapine, trimipramine, protriptyline, amitripty line, am itriptylines, and clomipramines could have a lightening effect on physical dependence on morphine. Expand
Effects of Magnesium sulfate and Bupropion on Morphine Induced tolerance in mice
TLDR
Magnesium sulfate and bupropion can be used to attenuate morphine induced tolerance and the possible mechanisms are antagonist behavior on N-methyl-D-aspartate (NMDA) receptor and inhibition of glutamate release, respectively. Expand
Acute Systemic Infusion of Bupropion Decrease Formalin Induced Pain Behavior in Rat
TLDR
Bupropion has analgesic effects at systemic application and the change of second phase of the pain behavior was significant and it revealed that central mechanisms involve in bupropion analgesia. Expand
Bupropion and its main metabolite reverse nicotine chronic tolerance in the mouse.
TLDR
Results indicate that bupropion's ability to promote smoking cessation may be partly due to its attenuation of nicotine tolerance since both measured responses of nicotine (antinociception and hypothermia) are mediated to a large extent by neuronal α4β2* nicotine receptors. Expand
Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)
Morphine-induced glial proinflammatory responses have been documented to contribute to tolerance to opioid analgesia. Here, we examined whether drugs previously shown to suppress glialExpand
Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment
TLDR
The present study did not put into evidence any DA activity of bupropion at the level of the cell body of mesolimbic/cortical DA neurons at a regimen exerting profound alterations of the firing activity of NE and 5-HT neurons. Expand
Analgesic and anti-inflammatory activities of bupropion in animal models
TLDR
The results showed that bupropion has analgesic and anti-inflammatory effects in animal models and further studies are needed to find out its mechanism of action. Expand
...
1
2
3
4
5
...